HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Other Products: In Vivo | Medtech Insight | Pink Sheet | Scrip | Generics Bulletin

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to HBW Insight? Start a free trial today!

Email
Share

Baker Heart & Diabetes Institute

http://www.baker.edu.au

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Vaxis Therapeutics Corp.

Bookmark

01 Feb 1999

By Maureen Riordan

Vaxis Therapeutics enters a market made popular by {Viagra}: it is developing both oral and local therapies for male and female sexual dysfunction.

BioPharmaceutical Strategy

See All

Company Information

Industry
Academic and Research Institutions

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Baker Heart & Diabetes Institute

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice